Claim OwnershipClinical Capsules
Subscribed: 14Played: 36
Subscribe
© 2025 TRC Healthcare
Description
On Clinical Capsules we bring you the same evidence-based insights you trust from TRC Healthcare, now in podcast form.
Every 2nd and 4th Tuesday, our expert editors from Pharmacist’s Letter, Prescriber Insights, and Pharmacy Technician’s Letter will break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.
TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses.
23 Episodes
Reverse
RSV prevention is more important than ever, and pharmacy teams are on the front lines. In this episode, TRC Healthcare Associate Editor, Vickie Danaher, PharmD, reviews who should receive RSV vaccines, recent changes to age and risk-based recommendations, and how monoclonal antibodies protect infants and high-risk children. You’ll also hear practical tips on the best time to vaccinate patients, co-administration with other vaccines, product nuances, and safety considerations to help con...
In this episode, Rachel Cole, PharmD, walks us through the evolving landscape of restless leg syndrome management, highlighting why dopamine agonists are no longer first-line therapy and what that means for clinical practice. You’ll learn about the importance of checking for iron deficiency, practical non-drug interventions, and alternative medications like gabapentin and pregabalin. Rachel shares actionable tips for educating patients, managing tricky cases, and staying up to dat...
In this episode, Rachel Cole, PharmD, explores the evolving landscape of medications for HIV pre-exposure prophylaxis (PrEP), spotlighting lenacapavir (Yeztugo)—a newly approved long-acting injectable option given just twice yearly. She walks through how it compares to oral therapies like Truvada and Descovy, plus other injectables such as cabotegravir. Rachel also offers practical guidance on identifying candidates for HIV PrEP, navigating lab requirements, and managing side effects.&n...
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, dives into the 2025/2026 flu vaccine season with a clear overview of what’s new and what remains consistent. From updated vaccine strain compositions and preferred products for older adults to thimerosal-free recommendations and egg allergy guidance, this episode equips you with the latest evidence-based insights. She also tackles common patient questions, discusses coadministration with COVID-19 and RSV vaccines, and shares pr...
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses how pharmacists and pharmacy technicians play a vital role in ensuring access to buprenorphine for opioid use disorder treatment. She’ll explore approaches to addressing dispensing barriers, inventory management strategies, and the importance of recognizing opioid use disorder as a chronic condition requiring appropriate long-term care. This is an excerpt from our March 2025 Pharmacy Essential Updates continuing e...
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, evaluates 3 new migraine treatments: Atzumi, Brekiya, and Symbravo. She'll explain their dosing techniques and how they compare to existing therapies, while providing practical guidance on clinical considerations and cost-effective alternatives for acute migraine management. This is an excerpt from our August 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit f...
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, unpacks the updated recommendations for H. pylori management, spotlighting why bismuth quadruple therapy is now front and center and how to navigate antibiotic resistance and patient-specific factors. You’ll come away with actionable pearls on regimen selection, adherence strategies, and which drug interactions to watch for. This is an excerpt from our February 2025 Pharmacy Essential Updates continuing education webinar serie...
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, digs into Suzetrigine—brand name Journavx—the first non-opioid analgesic approved in over two decades. You’ll hear how it works, how it compares to hydrocodone/acetaminophen, and why it might be a game-changer for patients at risk of opioid misuse. We’ll also unpack limitations in the clinical trials, cost concerns, dosing nuances, and key drug interactions to watch for. Plus, we’ll share tips for counseling patients and na...
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses recently approved drug formulations that bring fresh options—and new challenges—to the pharmacy counter. From Arbli, the first ready-to-use losartan suspension, to Emrosi, a low-dose minocycline for rosacea, and Opipza, an oral film version of aripiprazole, we’ll walk through what makes each product unique and what pharmacy teams should watch for. We also cover HemiClor, a 12.5 mg chlorthalidone tablet that may he...
In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS unpacks the newly approved use of tirzepatide (Zepbound) for obstructive sleep apnea (OSA)—a first-in-class pharmacologic option for a condition long managed with devices and lifestyle changes. You’ll hear a concise review of sleep apnea pathophysiology, how tirzepatide works to reduce airway obstruction, and what the latest clinical trials reveal about its efficacy and safety. Plus, you’ll get practical pharmacy-focuse...
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, guides listeners through the evolving landscape of biosimilars, highlighting their increasing presence in pharmacy practice and their critical distinctions from traditional generics. She explains the science behind biologics, the FDA’s rigorous approval process for biosimilars, and the nuances of interchangeability. With examples of biosimilars for Stelara, Humira, and Prolia, Vickie illustrates how pharmacists can confidently co...
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, delves into the debate about whether newer medications for Type 2 diabetes, including SGLT-2 inhibitors or GLP-1 agonists, should be used first-line instead of metformin. She examines the benefitsand drawbacks of these newer medications, including their cardiovascular and kidney benefits, side effects, and costs. This is an excerpt from our March 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resou...
In this episode, TRC Healthcare editor, Don Weinberger, PharmD, PMSP, explores how to avoid medication mishaps with pet prescriptions. Learn about common pitfalls, species-specific risks, and best practices for pharmacists and technicians. This is an excerpt from our December 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Ins...
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses Doxycycline Post-Exposure Prophylaxis for STIs. This is an excerpt from our August 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Chart: Drugs with Different Salt FormsChecklist: HIV Postexposure Prophylaxis (PEP) ChecklistChart: S...
In this episode, TRC Healthcare editor, Gina Corley, PharmD, discusses how to treat hyperhidrosis, or excessive sweating, including the use of a drug called sofpironium or Sofdra, which is a new topical agent approved for primary axillary hyperhidrosis. This is an excerpt from our November 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter...
In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS, discusses tailoring contraceptive use in certain populations based on updated US medical eligibility criteria, patient preferences, and medical history. This is an excerpt from our October 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: ...
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses the treatment of conjunctivitis, or pink eye. This is an excerpt from our July 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Article: Explain That Antibiotics Aren’t Often Needed for Pink EyeResource: The Ins and Outs of Eye and Ear Med...
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, answers the question… To Vitamin D or Not to Vitamin D? That’s right, this episode we explore the latest guidelines on Vitamin D Supplementation. This is an excerpt from our October 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Article: To “D”...
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, explains how the recently approved epinephrine nasal spray compares to the injectable products for treating anaphylaxis. This is an excerpt from our October 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Article: Explain How Epinephrine...
In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS, discusses a new drug for COPD, ensifentrine (Ohtuvayre). This is an excerpt from our September 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Article: Watch for Ensifentrine (Ohtuvayre) for COPDChart: Inhaled Medications for COPD Don’t...
Comments
Download from Google Play
Download from App Store
United States